SNHG14 and neoplasm: The overexpression of SNHG14 facilitated, whereas the use of anti-PD-L1 retarded the DLBCL tumor growth in mice, and anti-PD-L1 abrogated the facilitative effect of SNHG14 overexpression on tumor growth (Fig. 7b).